European Archives - Page 34 of 1125 - European Medical Journal

The Digital Shift: Integrating AI and Apps into Rheumatology Practice

In this episode we hear how big data, personalised medicine, and a holistic approach are revolutionising care for patients with rheumatoid arthritis.

AI-Powered Skin Imaging Shows Diagnostic Accuracy and Speed

Discover a recent study that indicates that autonomous total body photography could be a valuable tool in dermatological settings.

EBMT 2025 Interview: Janaki Vinnakota & Nicoletta Cieri

In this insightful interview, Janaki Vinnakota and Nicoletta Cieri speak on their individual, highly commended abstracts, to be presented…

Snapshots on Still’s: Short Expert Insights on the Management of Still’s Disease

In September 2024, the new EULAR/PReS recommendations on Still’s disease were published,1 bringing key updates to diagnosis and management…

ADHD Drugs and the Heart: Why All Prescriptions Need Monitoring

New study shows all ADHD medications, not just stimulants, affect cardiovascular parameters in children, adolescents, and adults.

Microultrasonography vs MRI: A Game-Changer for Prostate Biopsy

The study demonstrated that the use of microultrasonography-guided biopsy could provide an alternative to MRI.

Alexander Spira podcast

Onc Now: Episode 15: Rewriting the Rules of Lung Cancer Therapy

Alexander Spira, Director of the Thoracic and Phase I Program at Virginia Cancer Specialists, explores breakthroughs in lung and colorectal cancer treatment.

Pulmonary Rehabilitation Boosts Survival in Chronic Lung Diseases

Inpatient pulmonary rehabilitation significantly enhances functional independence in patients with chronic lung disease and extends survival.

Time to Enhancement Differences in UFMRI Linked to Malignancy in Breast Foci

UFMRI’s time to enhancement difference helps identify malignant foci, potentially reducing unnecessary breast biopsies.

Antenatal Opioids Linked to Reduced Brain Volumes in Newborns

New research shows that opioid-exposed newborns have 5% smaller brain volumes, varying by drug type.